首页 | 本学科首页   官方微博 | 高级检索  
检索        

4种头孢类抗生素治疗儿童支气管肺炎的成本-效果分析
引用本文:乔小云,孔戴艳,邵亚平.4种头孢类抗生素治疗儿童支气管肺炎的成本-效果分析[J].中国药房,2001,12(1):32-33.
作者姓名:乔小云  孔戴艳  邵亚平
作者单位:南京军区总医院药剂科,南京市210002
摘    要:目的研究头孢唑啉、头孢三嗪、头孢噻肟和头孢呋辛治疗儿童支气管肺炎的成本-效果。方法采用回顾性研究和成本-效果分析法,计算儿童支气管肺炎患者的治疗成本,进行药物经济学评价。结果头孢唑啉、头孢三嗪、头孢呋辛、头孢噻肟治疗儿童支气管肺炎的成本分别为512.84、725.42、796.28、734.16元。成本-效果比分别为93.68、475.83、517.30、412.28。结论与头孢三嗪、头孢呋辛和头孢噻肟相比,用头孢唑啉治疗儿童支气管肺炎最经济,但在评价某一药物治疗成本的同时,必须考虑药物的疗效和疗程。

关 键 词:儿童支气管肺炎  药物经济学  成本-效果
文章编号:1001-0408(2001)01-0031-02
修稿时间:2000年4月26日

Pharmacoeconomic Analysis of Treatment of Child Bronchopneumonia With Four Varieties of Cephalosporins
QIAO Xiaoyun,KONG Daiyan,SHAO Yaping.Pharmacoeconomic Analysis of Treatment of Child Bronchopneumonia With Four Varieties of Cephalosporins[J].China Pharmacy,2001,12(1):32-33.
Authors:QIAO Xiaoyun  KONG Daiyan  SHAO Yaping
Abstract:OBJECTIVE:To carry out the cost-effectiveness analysis of treating child bronchopneumonia with cefazolin,cefatrizine,cefataxime and cefuroxime METHODS:Using retrospective study and cost-effectiveness analysis,the costs of tre_atment of children with bronchopneumonia were calculated and pharmacoeconomically evaluated RESULTS:The costs of cefazolin,cefatrizine,cefuroxime and cefataxime in treatment of child bronchopneumonia were RMB 512 84,725 42,796 28 and 734 16 yuan and the cost-effectiveness ratios were 93 68,475 83,517 30 and 412 28 respectively CONCLUSION:In comparison with cefatrizine,cefuroxime and cefataxime,cefazolin is the most inexpensive one However,in evaluating the therapeutic cost of a drug, we should consider its therapeutic efficacy and course
Keywords:child bronchopneumonia  pharmacoeconomics  cost-effectiveness
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号